Outcomes of pancreatic cancer with liver oligometastasis

Liver oligometastatic pancreatic cancer (PC) may have favorable outcomes. This study aims to evaluate outcomes and factors associated with overall survival (OS) of these patients.

[1]  F. Sonohara,et al.  A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes , 2021, Anticancer Research.

[2]  J. Vermorken,et al.  Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond , 2021, Cancers.

[3]  M. Meijerink,et al.  Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review , 2021, Cancers.

[4]  N. Sasahira,et al.  Improved prognosis of pancreatic cancer patients with peritoneal metastasis. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[5]  S. K. Sherman,et al.  Surgical Management of Neuroendocrine Tumor Liver Metastases. , 2021, Surgical oncology clinics of North America.

[6]  T. Sato,et al.  Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial. , 2020, The British journal of surgery.

[7]  Ricky A. Sharma,et al.  The multidisciplinary management of oligometastases from colorectal cancer: a narrative review. , 2020, Annals of palliative medicine.

[8]  A. Quaas,et al.  Proposal for a definition of "Oligometastatic disease in pancreatic cancer" , 2019, BMC Cancer.

[9]  A. Saiura,et al.  Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? , 2019, Langenbeck's Archives of Surgery.

[10]  M. Büchler,et al.  CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  M. Del Chiaro,et al.  Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[12]  C. Braconi,et al.  Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  M. Wallace,et al.  Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study , 2018, Journal of pancreatic cancer.

[14]  D. Kwapisz.  Oligometastatic breast cancer , 2018, Breast Cancer.

[15]  Yongping Zhou,et al.  Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[16]  J. Windsor,et al.  International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[17]  K. Takaori.  "International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017": Will this pull us up out of the quagmire of confusing definitions and criteria? , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[18]  S. Popat,et al.  Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer , 2017, Clinical lung cancer.

[19]  Kun Wang,et al.  Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[20]  C. Bassi,et al.  Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? , 2017, Annals of Surgical Oncology.

[21]  K. Pienta,et al.  Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations , 2017, Nature Reviews Urology.

[22]  M. Reni,et al.  Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  elliot k fishman,et al.  Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-institutional Analysis , 2016, Journal of Gastrointestinal Surgery.

[24]  H. Imaoka,et al.  Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study , 2016, Pancreas.

[25]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[26]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[27]  F. Ames,et al.  Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.